Kennedy says he will finalize rules that increase diversity in clinical trials
By Julie Steenhuysen CHICAGO (Reuters) – Robert F. Kennedy Jr., President Donald Trump’s pick to lead the top U.S. health agency, told U.S. senators during his confirmation hearing on Wednesday that he would finalize regulations aimed at increasing the participation of diverse patient populations in clinical trials. The comment followed a purge last Friday of …
Kennedy says he will finalize rules that increase diversity in clinical trials Read More »









